Clinical Trial Update: A Comparison of the Drug Therapy Versus Re-Ablation [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing drug therapy versus repeat ablation for paroxysmal atrial fibrillation after failed initial ablation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Paroxysmal Atrial Fibrillation, Failed First Radiofrequency Ablation Procedure | Phase 2 | Status: COMPLETED